Beacon Pointe Advisors, LLC Onconova Therapeutics, Inc. Transaction History

Beacon Pointe Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.57 - $1.0 $605 - $1,062	-1,062 Reduced 7.71%	12,714 $7,000
Q1 2024 May 14, 2024	SELL	$0.67 - $1.01 $9,867 - $14,874	-14,727 Reduced 51.67%	13,776 $13,000
Q4 2023 Feb 08, 2024	BUY	$0.62 - $0.79 $45 - $57	73 Added 0.26%	28,503 $21,000
Q3 2023 Nov 14, 2023	BUY	$0.71 - $1.15 $9 - $14	13 Added 0.05%	28,430 $20,000
Q2 2023 Aug 11, 2023	BUY	$0.67 - $1.42 $10,241 - $21,706	15,286 Added 116.41%	28,417 $33,000
Q1 2023 May 12, 2023	SELL	$0.69 - $1.42 $18,082 - $37,213	-26,207 Reduced 66.62%	13,131 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.63 - $0.97 $6,063 - $9,335	-9,624 Reduced 19.66%	39,338 $25,000
Q3 2022 Nov 09, 2022	SELL	$0.95 - $1.45 $2,863 - $4,370	-3,014 Reduced 5.8%	48,962 $42,000
Q2 2022 Aug 11, 2022	BUY	$1.04 - $1.9 $6,186 - $11,303	5,949 Added 12.93%	51,976 $68,000
Q1 2022 May 17, 2022	BUY	$1.46 - $2.82 $39,998 - $77,256	27,396 Added 147.05%	46,027 $85,000
Q4 2021 Feb 14, 2022	SELL	$2.49 - $3.73 $19,444 - $29,127	-7,809 Reduced 29.53%	18,631 $48,000
Q3 2021 Nov 15, 2021	BUY	$3.81 - $6.76 $9,345 - $16,582	2,453 Added 10.23%	26,440 $101,000
Q2 2021 Aug 17, 2021	BUY	$6.28 - $16.2 $150,638 - $388,589	23,987 New	23,987 $166,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.